Article Details

Biotechs to test feasibility of a shelf-stable, powder mRNA COVID-19 vaccine

Retrieved on: 2021-03-10 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Biotechs to test feasibility of a shelf-stable, powder mRNA COVID-19 vaccine. View article details on hiswai:

Excerpt

The collaborators hope to make mRNA COVID-19 vaccines accessible to all by creating a shelf-stable, reconstitutable powder formulation.

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up